Neumora Therapeutics (NMRA) Other Operating Expenses (2023 - 2025)
Neumora Therapeutics (NMRA) recorded quarterly Other Operating Expenses of $5.0 million in Q3 2025, down 92.18% quarter-over-quarter from $63.9 million in Q4 2023.
Neumora Therapeutics (NMRA) Other Operating Expenses (2023 - 2025) Analysis & Trends
Neumora Therapeutics' Other Operating Expenses history runs 2 years deep, the most recent figure standing at $5.0 million for Q3 2025.
- In Q3 2025, Other Operating Expenses changed N/A year-over-year to $5.0 million; the TTM figure through Mar 2026 stood at $5.0 million (changed N/A YoY), while the FY2025 annual figure was $5.0 million, changed N/A from the prior year.
- Other Operating Expenses was $5.0 million for Q3 2025 at Neumora Therapeutics, down from $63.9 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $63.9 million in Q4 2023 to a low of $5.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Neumora Therapeutics | 270.71 Mn | 270.71 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 5.00 Mn |
| Dec 31, 2023 | 63.90 Mn |